Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 181

The DOI matches its Crossref record.

Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade)

Open access
Singh, Naveena, Hirschowitz, Lynn, Zaino, Richard, Alvarado-Cabrero, Isabel, Duggan, Maire A., Ali-Fehmi, Rouba, Euscher, Elizabeth, Hecht, Jonathan L., Horn, Lars-Christian, Ioffe, Olga, Matias-Guiu, Xavier, McCluggage, W. Glenn, Mikami, Yoshiki, Ordi, Jaume, Parkash, Vinita, Quddus, M. Ruhul, Quick, Charles M., Staebler, Annette, Zaloudek, Charles, Nucci, Marisa, Malpica, Anais, Oliva, Esther · 2019 · International Journal of Gynecological Pathology

Abstract

Although endometrial carcinoma (EC) is generally considered to have a good prognosis, over 20% of women with EC die of their disease, with a projected increase in both incidence and mortality over the next few decades. The aim of accurate prognostication is to ensure that patients receive optimal treatment and are neither overtreated nor undertreated, thereby improving patient outcomes overall. Patients with EC can be categorized into prognostic risk groups based on clinicopathologic findings. Other than tumor type and grade, groupings and recommended management algorithms may take into account age, body mass index, stage, and presence of lymphovascular space invasion. The molecular classification of EC that has emerged from the Cancer Genome Atlas (TCGA) study provides additional, potentially superior, prognostic information to traditional histologic typing and grading. This classifier does not, however, replace clinicopathologic risk assessment based on parameters other than histotype and grade. It is envisaged that molecular and clinicopathologic prognostic grouping systems will work better together than either alone. Thus, while tumor typing and grading may be superseded by a classification based on underlying genomic abnormalities, accurate assessment of other pathologic parameters will continue to be key to patient management. These include those factors related to staging, such as depth of myometrial invasion, cervical, vaginal, serosal surface, adnexal and parametrial invasion, and those independent of stage such as lymphovascular space invasion. Other prognostic parameters will also be discussed. These recommendations were developed from the International Society of Gynecological Pathologists Endometrial Carcinoma project.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/pgp.0000000000000524

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 181

Metadata

Authors
Singh, N., Hirschowitz, L., Zaino, R., Alvarado-Cabrero, I., Duggan, M. A., Ali-Fehmi, R., Euscher, E., Hecht, J. L., Horn, L.-C., Ioffe, O., Matias-Guiu, X., McCluggage, W. G., Mikami, Y., Ordi, J., Parkash, V., Quddus, M. R., Quick, C. M., Staebler, A., Zaloudek, C., Nucci, M., Malpica, A., & Oliva, E.
Venue
International Journal of Gynecological Pathology
Published
2019-01
Volume
38
Issue
Supplement 1
Pages
S93-S113
ISSN
0277-1691 (ISSN-L)
OpenAlex
W2903576199
Cited by
181
References
0
FWCI
13.51
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade). https://app.cochat.ai/papers/10.1097/pgp.0000000000000524
The paper
Singh, N., Hirschowitz, L., Zaino, R., Alvarado-Cabrero, I., Duggan, M. A., Ali-Fehmi, R., Euscher, E., Hecht, J. L., Horn, L.-C., Ioffe, O., Matias-Guiu, X., McCluggage, W. G., Mikami, Y., Ordi, J., Parkash, V., Quddus, M. R., Quick, C. M., Staebler, A., Zaloudek, C., . . . Oliva, E. (2019). Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade). International Journal of Gynecological Pathology. https://doi.org/10.1097/pgp.0000000000000524

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.